WHO, WIPO and WTO to hold health manufacturing symposium in Geneva

Traders Union
All News
Financial Institutions
Health manufacturing symposium Geneva 2026

Highlights

WHO, WIPO and WTO will hold the 13th Joint Technical Symposium in Geneva focusing on local and regional health products manufacturing, with registration open until 23 November 2026.
The symposium will address conditions for enabling ecosystems, including intellectual property, trade policy, technology transfer, digital health, and overcoming demand-side commercial barriers.
Event discussions aim to guide policy for sustainable, affordable access to health technologies by integrating health, trade, and IP frameworks to strengthen supply chain resilience.

Symposium agenda and participation details

As reported by the World Trade Organization, the 13th Joint Technical Symposium is being organized together with the World Health Organization and the World Intellectual Property Organization, with WHO hosting the event at the International Conference Centre Geneva. Registration remains open until 23 November 2026, and the meeting is open to the public, with in-person attendance and virtual participation available on request.

The symposium is focusing on the conditions needed to build enabling ecosystems for local and regional health products manufacturing, including health systems, intellectual property frameworks and trade policies. It is also examining demand-side barriers to commercial viability, the role of cooperation and technology transfer, lessons from national and regional initiatives, and the opportunities and challenges linked to digital health and artificial intelligence.

WHO Director-General Dr. Tedros Adhanom Ghebreyesus, WIPO Director General Daren Tang and WTO Director-General Dr. Ngozi Okonjo-Iweala are due to open the event. Their remarks are set to be followed by a keynote address and three thematic panel discussions covering public health policy integration, IP frameworks for innovation and manufacturing, and trade as a support for local production and supply chain resilience.

Implications for health technology supply chains

The three organizations are positioning the event around a broader policy question, how to make local and regional production contribute to sustainable access to quality-assured, safe, effective and affordable health technologies. The underlying argument is that manufacturing capacity alone is not enough without regulatory systems, investment, market access and coherent legal frameworks.

That framing places the symposium at the intersection of health policy and industrial strategy, particularly for regions seeking to reduce supply vulnerabilities and expand domestic or regional production capability. By bringing together trade, IP and health policy discussions in one forum, the event is intended to support dialogue on how governments and other stakeholders can build more resilient and commercially workable health manufacturing ecosystems.

Our earlier coverage of the WTO’s outlook highlighted how wars, tariffs, and recurring disruptions are prompting companies and governments to reconfigure trade flows and build more resilient supply chains, even at higher cost. The article also noted that regionalization of trade is likely to accelerate, while demand tied to AI-related products can partially offset conflict-driven shocks—though uncertainty remains elevated.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.